GAPDH and colorectal carcinoma: Overexpression of GAPDH has been linked to poorer prognosis in several solid tumors, including colorectal cancer (CRC) (Tarrado-Castellarnau et al., 2017) and NSCLC (Puzone et al., 2013; Wang, D et al., 2013).